Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03703583
Other study ID # 17.12.INF
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 9, 2018
Est. completion date December 31, 2019

Study information

Verified date October 2023
Source Société des Produits Nestlé (SPN)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Multi-country, cross-sectional, observational study in diverse geographic locations all over the world.


Description:

This is a cross-sectional single time point study. Infants and caregivers who come to a clinic for a routine health visit who wish to participate in the study by signing the consent form and meet all inclusion criteria/exclusion criteria will be enrolled. At the visit, a research staff member will assist the parents to complete (i) Feeding Practice and Gut Comfort Questionnaire and (ii) Infant Gastrointestinal Symptom (IGSQ)-13 items. Additionally, infant's anthropometrics (weight, length, head circumference) will be recorded. These anthropometrics will be measured by the researcher as part of the routine visit.


Recruitment information / eligibility

Status Completed
Enrollment 2804
Est. completion date December 31, 2019
Est. primary completion date December 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Weeks to 4 Months
Eligibility Inclusion Criteria: - Healthy full term (37-42 weeks of gestation) singleton infant. - Postnatal age = 6 weeks and = 4 months - Parent as primary Caregiver and = 18 years old - Exclusively/predominantly breastfeeding or exclusively/predominantly formula feeding of the same type/brand, for at least the past 2 weeks. - Evidence of personally signed and dated informed consent document by the infant's parent(s). Exclusion Criteria: - Chronic illness necessitating medical follow up - Acute ongoing or recent (last 2 weeks) illness necessitating medical follow up - Any known case of food allergy (e.g milk) - Caregivers who are not likely to comply with the study procedures

Study Design


Related Conditions & MeSH terms


Intervention

Other:
There is no intervention in this observational study.
There is no intervention in this observational study.

Locations

Country Name City State
Egypt Alexandria University Alexandria
Egypt Assuit University Assiut
Egypt Ain Shams University Cairo
Egypt Cairo University Cairo
Egypt Tanta University Tanta
Egypt Zagazig University Zagazig
India Apollo Children's Hospital Chennai
India ICH Hospital Kolkata
India Dr Praveen Gokhales Childrens Clinic and Vaccination Centre Thane
Indonesia Faculty of Medicine Universitas Gadjah Mada Yogyakarta
Malaysia University of Malaya Kuala Lumpur
Pakistan PIMS Islamabad
Pakistan National Institute of Child Health Karachi
Pakistan The Children Hospital & Institute of Child Health Lahore
Pakistan BBH Rawalpindi
Philippines St.Luke'S College of Medicine Quezon City

Sponsors (1)

Lead Sponsor Collaborator
Société des Produits Nestlé (SPN)

Countries where clinical trial is conducted

Egypt,  India,  Indonesia,  Malaysia,  Pakistan,  Philippines, 

Outcome

Type Measure Description Time frame Safety issue
Primary An index score of overall GI symptom burden Measured by Validated, standardized infant Gastrointestinal Symptom Questionnaire (IGSQ-13) single time point between 6 weeks to 4 months
Secondary GI Symptoms measured by IGSQ-13 questionnaires (An overall index score is calculated from 13 questions in the questionnaire as a measure of total GI symptom burden. The values for the IGSQ index score can range from 13 (low GI burden) to 65 (high GI burden)) single time point between 6 weeks to 4 months
Secondary Stool characteristics measured by Feeding Practice and Gut Comfort Questionnaire (frequency and consistency) one day recall before study visit
Secondary Physician-reported and parent-reported Colic measured by Feeding Practice and Gut Comfort Questionnaire based on ROME IV diagnosis criteria. Effect of feeding group on the prevalence of colic will be assessed by logistic regression. Single time point between 6 weeks to 4 months
See also
  Status Clinical Trial Phase
Completed NCT03679234 - Impact of Infant Formula on Caregiver-perceived Intolerance N/A
Completed NCT01681355 - Gastrointestinal Tolerance Study of a New Infant Formula N/A
Completed NCT04962594 - Safety and Efficacy of Infant Formulas Supplemented With Pre- and Probiotic(s) N/A
Completed NCT03722550 - Second Generation Human Milk Oligosaccharides Blend Study N/A
Completed NCT01515644 - Study on the Effect of Inulin in Infant Formula on Gut Health Phase 3
Completed NCT03014115 - Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in Infants N/A
Recruiting NCT06053112 - The Trial of a New Infant Formula in Healthy Term Chinese Infants N/A
Completed NCT03000543 - Novel Isotope Dilution Technique to Assess Vitamin A Status N/A
Not yet recruiting NCT06361719 - Efficacy of Two HMOs in Chinese Infants N/A
Terminated NCT03976596 - Measurement of in Vivo Mitochondrial Capacity in Infants
Recruiting NCT01601197 - A Study of Two Injection Techniques to Reduce Pain in Infants Undergoing Immunization Phase 3
Completed NCT01635816 - Immunogenicity of SA 14-14-2 JE Vaccine Phase 4
Completed NCT01633216 - Poliovirus Vaccine Trial in Bangladesh Phase 4
Completed NCT00957892 - Effects of Infant Formula Composition on Infant Feeding Behaviors N/A
Completed NCT03801161 - Influence of Inflammation on Micronutrient Status Assessment N/A
Active, not recruiting NCT06073652 - Starter Infant Formula With Synbiotics N/A
Completed NCT01825109 - Improving Rotavirus Vaccine Immune Response Phase 3
Completed NCT01594840 - Changing Chat: Diaper Tips to Improve Language Development N/A
Withdrawn NCT01507935 - Colonisation Resistance Study Phase 2
Not yet recruiting NCT01249911 - Lactobacillus Reuteri DSM 17938 and Prevention of Respiratory and Gastrointestinal Infections in Mexican Infants Phase 3